検索結果

ed approval for a partial change in the marketing authorization of “Aibeta® Combination Eye Drops” (generic name: brimonidine tartrate and timolol maleate, hereinafter referred to as “the new formulat...

ed approval for a partial change in the marketing authorization of “Aibeta® Combination Eye Drops” (generic name: brimonidine tartrate and timolol maleate, hereinafter referred to as “the new formulat...

Product Development Policy | Research & Development | SENJU Pharmaceutica

dry eye therapies. We also contributed to reducing the economic burden on patients by using various generic drugs and biosimilars. At the same time, eye diseases remain a significant global health cha...

hei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic Suspension 0.3%” (Generic Name: Motugivatrep; hereinafter: Avarept® ), discovered and licensed from Mochida Pharmaceut...

hei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licens...